G170

Experimentelle Therapien hämatologischer Neoplasien Also known as:G170
IDI:(DE-He78)G170-20160331

Recent Publications

All known publications ...
Download: BibTeX | EndNote XML,  Text | RIS | 

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Dissertation / PhD Thesis
Signaling Pathway Profiling in Multiple Myeloma
Dissertation, Universität Heidelberg, 2018  GO BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Dissertation / PhD Thesis
The influence of centrosome amplification and clustering on cell migration and invasion
Dissertation, Universität Heidelberg, 2018  GO BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;  ;
Oncogene-induced senescence: a potential breakpoint mechanism against malignant transformation in plasma cell disorders.
Leukemia and lymphoma 59(11), 2660 - 2669 () [10.1080/10428194.2018.1443450]  GO BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;
Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma.
The New England journal of medicine 379(19), 1811 - 1822 () [10.1056/NEJMoa1805762]  GO BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma.
Blood 132(6), 587-597 () [10.1182/blood-2018-03-840132]  GO pmc   Download fulltextFulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;  ;
Cytogenetic abnormalities in monoclonal gammopathy of undetermined significance.
Leukemia 32(12), 2717-2719 () [10.1038/s41375-018-0202-1]  GO BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;
Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma.
Blood advances 2(1), 1 - 9 () [10.1182/bloodadvances.2017013334]  GO pmc   Download fulltextFulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;
The orally available multikinase inhibitor regorafenib (BAY 73-4506) in multiple myeloma.
Annals of hematology 97(5), 839-849 () [10.1007/s00277-018-3237-5]  GO BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;
Therapeutic monoclonal antibodies in combination with pomalidomide can overcome refractoriness to both agents in multiple myeloma: A case-based approach.
Hematological oncology 36(1), 258 - 261 () [10.1002/hon.2473]  GO BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;  ;
Analysis of long-term survival in multiple myeloma after first-line autologous stem cell transplantation: impact of clinical risk factors and sustained response.
Cancer medicine 7(2), 307 - 316 () [10.1002/cam4.1283]  GO DBCoverage   Download fulltextFulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

All known publications ...
Download: BibTeX | EndNote XML,  Text | RIS | 


 Record created 2017-01-13, last modified 2022-03-18



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)